Inmaculada Gilaberte

2.4k total citations
67 papers, 1.8k citations indexed

About

Inmaculada Gilaberte is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Inmaculada Gilaberte has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Psychiatry and Mental health, 29 papers in Pharmacology and 13 papers in Experimental and Cognitive Psychology. Recurrent topics in Inmaculada Gilaberte's work include Treatment of Major Depression (27 papers), Schizophrenia research and treatment (15 papers) and Bipolar Disorder and Treatment (14 papers). Inmaculada Gilaberte is often cited by papers focused on Treatment of Major Depression (27 papers), Schizophrenia research and treatment (15 papers) and Bipolar Disorder and Treatment (14 papers). Inmaculada Gilaberte collaborates with scholars based in Spain, United States and United Kingdom. Inmaculada Gilaberte's co-authors include Enric Álvarez, Víctor Pérez, Pepa Polavieja, Antonio Ciudad, Francesc Artigas, Luis San, Douglas E. Faries, Irene Romera, Julio Bobes and Rodrigo Escobar and has published in prestigious journals such as The Lancet, PEDIATRICS and The British Journal of Psychiatry.

In The Last Decade

Inmaculada Gilaberte

61 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inmaculada Gilaberte Spain 23 1.0k 595 356 313 220 67 1.8k
Olli Kampman Finland 28 975 1.0× 380 0.6× 487 1.4× 199 0.6× 182 0.8× 112 2.1k
Petter Andreas Ringen Norway 25 1.7k 1.7× 328 0.6× 510 1.4× 217 0.7× 211 1.0× 52 2.3k
Dov Aizenberg Israel 29 1.7k 1.7× 357 0.6× 721 2.0× 219 0.7× 183 0.8× 95 2.7k
Avi Reichenberg United States 14 605 0.6× 394 0.7× 234 0.7× 227 0.7× 320 1.5× 28 1.3k
J. Peuskens Belgium 11 1.2k 1.2× 274 0.5× 436 1.2× 159 0.5× 93 0.4× 19 1.9k
Manuel Bousoño Spain 21 895 0.9× 184 0.3× 612 1.7× 207 0.7× 163 0.7× 61 1.6k
Brian A. Palmer United States 19 859 0.8× 372 0.6× 646 1.8× 154 0.5× 91 0.4× 44 1.7k
Rune A. Kroken Norway 24 1.0k 1.0× 219 0.4× 327 0.9× 212 0.7× 560 2.5× 95 1.8k
I Hui Lee Taiwan 24 902 0.9× 271 0.5× 460 1.3× 430 1.4× 481 2.2× 117 2.3k
Howard C. Margolese Canada 23 1.2k 1.2× 236 0.4× 413 1.2× 116 0.4× 106 0.5× 64 1.9k

Countries citing papers authored by Inmaculada Gilaberte

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Gilaberte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Gilaberte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Gilaberte more than expected).

Fields of papers citing papers by Inmaculada Gilaberte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Gilaberte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Gilaberte. The network helps show where Inmaculada Gilaberte may publish in the future.

Co-authorship network of co-authors of Inmaculada Gilaberte

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Gilaberte. A scholar is included among the top collaborators of Inmaculada Gilaberte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Gilaberte. Inmaculada Gilaberte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pérez-Castrillón, José-Luis, Esteban Jódar, Ján Nociar, et al.. (2025). A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency. Nutrients. 17(4). 672–672.
3.
4.
Majorek‐Olechowska, Bernadetta, et al.. (2024). Pharmacokinetics and Safety of Bilastine 10 mg/d in Children Aged 2 to 5 Years With Allergic Rhinoconjunctivitis or Urticaria: A Phase 3 Clinical Trial. Journal of Investigational Allergology and Clinical Immunology. 35(4). 267–275. 1 indexed citations
5.
Jódar, Esteban, José-Luis Pérez-Castrillón, Ján Nociar, et al.. (2024). Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial. Nutrients. 16(22). 3796–3796. 1 indexed citations
6.
7.
8.
Romera, Irene, Víctor Pérez, Deborah Quail, et al.. (2014). Individual residual symptoms and functional impairment in patients with depression. Psychiatry Research. 220(1-2). 258–262. 19 indexed citations
9.
Romera, Irene, Ángel L. Montejo, Enric Aragonès, et al.. (2013). Systematic depression screening in high-risk patients attending primary care: a pragmatic cluster-randomized trial. BMC Psychiatry. 13(1). 83–83. 24 indexed citations
10.
Gilaberte, Inmaculada, Irene Romera, Víctor Pérez, José M. Menchón, & Alexander Schacht. (2012). Different levels of lack of improvement at 4 weeks of escitalopram treatment as predictors of poor 8-week outcome in MDD. Journal of Affective Disorders. 146(3). 433–437. 5 indexed citations
11.
Romera, Irene, Víctor Pérez, José M. Menchón, et al.. (2012). Early Switch Strategy in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 32(4). 479–486. 24 indexed citations
12.
Romera, Irene, Víctor Pérez, José M. Menchón, et al.. (2012). Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: A double-blind randomized study. Journal of Affective Disorders. 143(1-3). 47–55. 19 indexed citations
13.
14.
Montoya, Alonso, Mauricio Tohen, Eduard Vieta, et al.. (2010). Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: A 1-year, prospective, observational cohort study. Journal of Affective Disorders. 127(1-3). 50–57. 20 indexed citations
15.
Ramón, Diego J., et al.. (2009). Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample. International Journal of Psychiatry in Clinical Practice. 13(2). 100–108. 3 indexed citations
16.
17.
Montoya, Alonso, et al.. (2007). [Bipolar disorder in Spain: functional status and resource use on the basis of the Spanish sample of the observational, Pan European EMBLEM study].. PubMed. 18(71). 13–9. 3 indexed citations
18.
Hudson, James I., David Pérahia, Inmaculada Gilaberte, et al.. (2007). Duloxetine in the treatment of major depressive disorder: an open-label study. BMC Psychiatry. 7(1). 43–43. 23 indexed citations
19.
Árias, F., et al.. (1999). [Comparative naturalistic study of the efficacy and tolerability of new antidepressants].. PubMed. 26(6). 351–7. 1 indexed citations
20.
Árias, F., et al.. (1998). Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting. International Journal of Psychiatry in Clinical Practice. 2(4). 255–260. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olli Kampman Breakdown of academic impact, for papers by Petter Andreas Ringen Breakdown of academic impact, for papers by Dov Aizenberg Breakdown of academic impact, for papers by Avi Reichenberg Breakdown of academic impact, for papers by J. Peuskens Breakdown of academic impact, for papers by Manuel Bousoño Breakdown of academic impact, for papers by Brian A. Palmer Breakdown of academic impact, for papers by Rune A. Kroken Breakdown of academic impact, for papers by I Hui Lee Breakdown of academic impact, for papers by Howard C. Margolese
Rankless by CCL
2026